Abstract
Summary
The global market for Vaccine Administration was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccine Administration, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Vaccine Administration by region & country, by Type, and by Application.
The Vaccine Administration market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Administration.
Market Segmentation
By Company
Pfizer
AstraZeneca
Sanofi Aventis
Merck
GlaxoSmithKline
Emergent BioSolutions
Johnson & Johnson
CSL Limited
Serum Institute of India
Bharat Biotech
VBI Vaccines
Sinovac Biotech
Segment by Type:
Viral Diseases
Bacterial Diseases
Segment by Application
Paediatrics
Adults
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Vaccine Administration manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Vaccine Administration in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Vaccine Administration in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccine Administration, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Vaccine Administration by region & country, by Type, and by Application.
The Vaccine Administration market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Administration.
Market Segmentation
By Company
Pfizer
AstraZeneca
Sanofi Aventis
Merck
GlaxoSmithKline
Emergent BioSolutions
Johnson & Johnson
CSL Limited
Serum Institute of India
Bharat Biotech
VBI Vaccines
Sinovac Biotech
Segment by Type:
Viral Diseases
Bacterial Diseases
Segment by Application
Paediatrics
Adults
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Vaccine Administration manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Vaccine Administration in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Vaccine Administration in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Vaccine Administration Product Introduction
1.2 Global Vaccine Administration Market Size Forecast
1.3 Vaccine Administration Market Trends & Drivers
1.3.1 Vaccine Administration Industry Trends
1.3.2 Vaccine Administration Market Drivers & Opportunity
1.3.3 Vaccine Administration Market Challenges
1.3.4 Vaccine Administration Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Vaccine Administration Players Revenue Ranking (2023)
2.2 Global Vaccine Administration Revenue by Company (2019-2024)
2.3 Key Companies Vaccine Administration Manufacturing Base Distribution and Headquarters
2.4 Key Companies Vaccine Administration Product Offered
2.5 Key Companies Time to Begin Mass Production of Vaccine Administration
2.6 Vaccine Administration Market Competitive Analysis
2.6.1 Vaccine Administration Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Vaccine Administration Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Administration as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Viral Diseases
3.1.2 Bacterial Diseases
3.2 Global Vaccine Administration Sales Value by Type
3.2.1 Global Vaccine Administration Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Vaccine Administration Sales Value, by Type (2019-2030)
3.2.3 Global Vaccine Administration Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Paediatrics
4.1.2 Adults
4.2 Global Vaccine Administration Sales Value by Application
4.2.1 Global Vaccine Administration Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Vaccine Administration Sales Value, by Application (2019-2030)
4.2.3 Global Vaccine Administration Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Vaccine Administration Sales Value by Region
5.1.1 Global Vaccine Administration Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Vaccine Administration Sales Value by Region (2019-2024)
5.1.3 Global Vaccine Administration Sales Value by Region (2025-2030)
5.1.4 Global Vaccine Administration Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Vaccine Administration Sales Value, 2019-2030
5.2.2 North America Vaccine Administration Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Vaccine Administration Sales Value, 2019-2030
5.3.2 Europe Vaccine Administration Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Vaccine Administration Sales Value, 2019-2030
5.4.2 Asia Pacific Vaccine Administration Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Vaccine Administration Sales Value, 2019-2030
5.5.2 South America Vaccine Administration Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Vaccine Administration Sales Value, 2019-2030
5.6.2 Middle East & Africa Vaccine Administration Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Vaccine Administration Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Vaccine Administration Sales Value
6.3 United States
6.3.1 United States Vaccine Administration Sales Value, 2019-2030
6.3.2 United States Vaccine Administration Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Vaccine Administration Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Vaccine Administration Sales Value, 2019-2030
6.4.2 Europe Vaccine Administration Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Vaccine Administration Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Vaccine Administration Sales Value, 2019-2030
6.5.2 China Vaccine Administration Sales Value by Type (%), 2023 VS 2030
6.5.3 China Vaccine Administration Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Vaccine Administration Sales Value, 2019-2030
6.6.2 Japan Vaccine Administration Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Vaccine Administration Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Vaccine Administration Sales Value, 2019-2030
6.7.2 South Korea Vaccine Administration Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Vaccine Administration Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Vaccine Administration Sales Value, 2019-2030
6.8.2 Southeast Asia Vaccine Administration Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Vaccine Administration Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Vaccine Administration Sales Value, 2019-2030
6.9.2 India Vaccine Administration Sales Value by Type (%), 2023 VS 2030
6.9.3 India Vaccine Administration Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer Vaccine Administration Products, Services and Solutions
7.1.4 Pfizer Vaccine Administration Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Profile
7.2.2 AstraZeneca Main Business
7.2.3 AstraZeneca Vaccine Administration Products, Services and Solutions
7.2.4 AstraZeneca Vaccine Administration Revenue (US$ Million) & (2019-2024)
7.2.5 AstraZeneca Recent Developments
7.3 Sanofi Aventis
7.3.1 Sanofi Aventis Profile
7.3.2 Sanofi Aventis Main Business
7.3.3 Sanofi Aventis Vaccine Administration Products, Services and Solutions
7.3.4 Sanofi Aventis Vaccine Administration Revenue (US$ Million) & (2019-2024)
7.3.5 Merck Recent Developments
7.4 Merck
7.4.1 Merck Profile
7.4.2 Merck Main Business
7.4.3 Merck Vaccine Administration Products, Services and Solutions
7.4.4 Merck Vaccine Administration Revenue (US$ Million) & (2019-2024)
7.4.5 Merck Recent Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Profile
7.5.2 GlaxoSmithKline Main Business
7.5.3 GlaxoSmithKline Vaccine Administration Products, Services and Solutions
7.5.4 GlaxoSmithKline Vaccine Administration Revenue (US$ Million) & (2019-2024)
7.5.5 GlaxoSmithKline Recent Developments
7.6 Emergent BioSolutions
7.6.1 Emergent BioSolutions Profile
7.6.2 Emergent BioSolutions Main Business
7.6.3 Emergent BioSolutions Vaccine Administration Products, Services and Solutions
7.6.4 Emergent BioSolutions Vaccine Administration Revenue (US$ Million) & (2019-2024)
7.6.5 Emergent BioSolutions Recent Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Profile
7.7.2 Johnson & Johnson Main Business
7.7.3 Johnson & Johnson Vaccine Administration Products, Services and Solutions
7.7.4 Johnson & Johnson Vaccine Administration Revenue (US$ Million) & (2019-2024)
7.7.5 Johnson & Johnson Recent Developments
7.8 CSL Limited
7.8.1 CSL Limited Profile
7.8.2 CSL Limited Main Business
7.8.3 CSL Limited Vaccine Administration Products, Services and Solutions
7.8.4 CSL Limited Vaccine Administration Revenue (US$ Million) & (2019-2024)
7.8.5 CSL Limited Recent Developments
7.9 Serum Institute of India
7.9.1 Serum Institute of India Profile
7.9.2 Serum Institute of India Main Business
7.9.3 Serum Institute of India Vaccine Administration Products, Services and Solutions
7.9.4 Serum Institute of India Vaccine Administration Revenue (US$ Million) & (2019-2024)
7.9.5 Serum Institute of India Recent Developments
7.10 Bharat Biotech
7.10.1 Bharat Biotech Profile
7.10.2 Bharat Biotech Main Business
7.10.3 Bharat Biotech Vaccine Administration Products, Services and Solutions
7.10.4 Bharat Biotech Vaccine Administration Revenue (US$ Million) & (2019-2024)
7.10.5 Bharat Biotech Recent Developments
7.11 VBI Vaccines
7.11.1 VBI Vaccines Profile
7.11.2 VBI Vaccines Main Business
7.11.3 VBI Vaccines Vaccine Administration Products, Services and Solutions
7.11.4 VBI Vaccines Vaccine Administration Revenue (US$ Million) & (2019-2024)
7.11.5 VBI Vaccines Recent Developments
7.12 Sinovac Biotech
7.12.1 Sinovac Biotech Profile
7.12.2 Sinovac Biotech Main Business
7.12.3 Sinovac Biotech Vaccine Administration Products, Services and Solutions
7.12.4 Sinovac Biotech Vaccine Administration Revenue (US$ Million) & (2019-2024)
7.12.5 Sinovac Biotech Recent Developments
8 Industry Chain Analysis
8.1 Vaccine Administration Industrial Chain
8.2 Vaccine Administration Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Vaccine Administration Sales Model
8.5.2 Sales Channel
8.5.3 Vaccine Administration Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer